Please provide your email address to receive an email when new articles are posted on . Adults with diabetes receiving both basal and bolus insulin through a smart pen miss about six doses every 14 ...
COMBINE 3 phase 3a trial successfully completed with once-weekly IcoSema demonstrating non-inferior reduction in HbA1c versus daily basal-bolus treatment (insulin glargine U100 and insulin aspart) in ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA has cleared the Omnipod Go for use by adults ...
Hosted on MSN
What Is an Insulin Pump?
Insulin pumps are the most advanced insulin delivery technology available today for people with type 1 and type 2 diabetes. An insulin pump replaces injections with a syringe or insulin pen, using an ...
The US Food and Drug Administration has approved insulin icodec (Awiqli), developed by Novo Nordisk, as the first once-weekly long-acting basal insulin for glycemic control in adults with Type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results